Serina Therapeutics
Price & Volume
Stats
See more52W Range | $1.42-$7.92 |
Market Cap | $16.8M |
Shares Short | 130,122 |
Financials
See moreRevenue (12 Mos) | $116,000 |
Revenue Growth (YoY) | 154.9% |
Gross Profit (12 Mos) | -$12M |
Diluted EPS | -$1.87 |
News
See moreYahoo Finance • 24 days ago
Serina Therapeutics Announces First Patient Enrolled in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson's Disease
Yahoo Finance • 4 months ago
Serina Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
Yahoo Finance • 4 months ago
Serina Therapeutics Provides Regulatory Update on SER-252 Program
About
CEO | Mr. Steven A. Ledger |
Address | 601 Genome Way, Huntsville, AL, United States, 35806 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 12 |
